You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,517,564


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,517,564
Title:Methods of treatment for cystic fibrosis
Abstract:Compound I of the formula (I) and/or pharmaceutically acceptable salt(s) of Compound I comprised in a pharmaceutical composition and methods of using the same to treat cystic fibrosis.
Inventor(s):Chen Weichao George, Haseltine Eric L., Moskowitz Samuel, Robertson Sarah, Waltz David
Assignee:Vertex Pharmaceuticals Incorporated
Application Number:US16629472
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using the Example of U.S. Patent 11,517,564

Understanding the Importance of Patent Analysis

Patent analysis is a crucial step in understanding the intellectual property landscape, identifying potential gaps, and ensuring compliance with existing patents. This article will guide you through the process of analyzing the scope and claims of a U.S. patent, using U.S. Patent 11,517,564 as an example.

Accessing Patent Information

To begin analyzing a patent, you need to access the patent document. The U.S. Patent and Trademark Office (USPTO) provides several tools for this purpose:

  • Patent Public Search: This is a modern web-based patent search application that offers enhanced access to prior art and patent documents[1].
  • USPTO Website: You can search for patents directly on the USPTO website, where full text and images are available for patents from 1976 onwards[4].

Identifying the Patent

For this example, let's assume you have located U.S. Patent 11,517,564 through the USPTO's search tools.

Reading the Patent Document

Title and Abstract

The title and abstract provide a brief overview of the invention. This section helps in understanding the general scope of the patent.

Background of the Invention

This section explains the context and prior art related to the invention. It helps in identifying the problems the patent aims to solve.

Summary of the Invention

The summary provides a concise description of the invention, including its key features and advantages.

Analyzing the Claims

Understanding Claims

Claims are the most critical part of a patent application as they define the scope of protection. They must be clear, concise, and supported by the description and drawings[3].

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims.

Claim Charts and Scope Concepts

To analyze claims effectively, you can use claim charts and scope concepts. These tools help in categorizing patents by claims and overarching scope concepts, making it easier to filter, search, and analyze large numbers of patent claims[3].

Evaluating the Scope of Protection

Claim Coverage Matrix

A Claim Coverage Matrix shows which patents and claims are actively protecting your intellectual property and where gaps or opportunities exist. This matrix helps in determining the value of each claim to your company[3].

Scope Concepts

Scope concepts link claims on similar patents, providing a powerful categorization tool. These concepts can be categorized as high, medium, or low value based on their current and future relevance to your company[3].

Reviewing the Patent Landscape

Global Dossier

The Global Dossier service allows you to see the patent family for a specific application, including related applications filed at participating IP Offices. This helps in understanding the global patent landscape and identifying potential overlaps or gaps[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This tool enables you to visualize search results from several offices on a single page[1].

Utilizing Additional Resources

Patent and Trademark Resource Centers (PTRCs)

Your nearest PTRC can provide local search resources and training in patent search techniques, which can be invaluable in conducting a thorough analysis[1].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist with complex searches[1].

Engaging Experts and Tools

Consulting with Experts

Engage with patent attorneys, engineers, and scientists to review claim charts and determine whether a particular scope concept is applicable to a target product or method. This collaborative approach ensures a comprehensive analysis[3].

Using Software Tools

Tools like ClaimScape® software generate interactive claim charts that can be reviewed by technical experts. These charts help in identifying gaps in current coverage and highlighting future design opportunities[3].

Key Takeaways

  • Access to Information: Use the USPTO's Patent Public Search and other resources to access the patent document.
  • Claims Analysis: Focus on independent and dependent claims, and use claim charts and scope concepts to evaluate the scope of protection.
  • Global Perspective: Utilize the Global Dossier and CCD to understand the global patent landscape.
  • Expert Input: Engage with experts and use specialized software tools to ensure a thorough analysis.
  • Continuous Monitoring: Regularly update your analysis as new patents are filed or as you explore other avenues of development.

FAQs

Q: How can I access the full text of a U.S. patent?

A: You can access the full text and images of U.S. patents from 1976 onwards directly on the USPTO website. For patents prior to 1976, images and current classification numbers are available, but full text may not be[4].

Q: What is the purpose of a Claim Coverage Matrix?

A: A Claim Coverage Matrix helps in identifying which patents and claims are actively protecting your intellectual property and where gaps or opportunities exist[3].

Q: How can I determine the global patent landscape for a specific invention?

A: Use the Global Dossier service to see the patent family for a specific application, including related applications filed at participating IP Offices[1].

Q: What is the Common Citation Document (CCD)?

A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, enabling you to visualize search results from several offices on a single page[1].

Q: Where can I get training in patent search techniques?

A: You can get training in patent search techniques at your nearest Patent and Trademark Resource Center (PTRC) or the USPTO Public Search Facility[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SLWIP - Patent Analytics: https://www.slwip.com/services/patent-analytics/
  4. NYPL Libguides - How to Search for an Historical U.S. Patent: https://libguides.nypl.org/patents/historical_patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,517,564

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor GRANULES;ORAL 217660-001 Apr 26, 2023 RX Yes No 11,517,564 ⤷  Subscribe Y TREATMENT OF CYSTIC FIBROSIS IN PATIENTS AGED 2 TO ⤷  Subscribe
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor GRANULES;ORAL 217660-002 Apr 26, 2023 RX Yes Yes 11,517,564 ⤷  Subscribe Y TREATMENT OF CYSTIC FIBROSIS IN PATIENTS AGED 2 TO ⤷  Subscribe
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor TABLET;ORAL 212273-002 Jun 8, 2021 RX Yes No 11,517,564 ⤷  Subscribe Y TREATMENT OF CYSTIC FIBROSIS IN PATIENTS AGED 6 YEARS AND OLDER WHO HAVE IN THE CFTR GENE AT LEAST ONE F508DEL MUTATION OR A MUTATION THAT IS RESPONSIVE BASED ON IN VITRO DATA BY ADMINISTERING DAILY ELX (200 MG OR 100 MG); TEZ; AND IVA ⤷  Subscribe
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor TABLET;ORAL 212273-001 Oct 21, 2019 RX Yes Yes 11,517,564 ⤷  Subscribe Y TREATMENT OF CYSTIC FIBROSIS IN PATIENTS AGED 6 YEARS AND OLDER WHO HAVE IN THE CFTR GENE AT LEAST ONE F508DEL MUTATION OR A MUTATION THAT IS RESPONSIVE BASED ON IN VITRO DATA BY ADMINISTERING DAILY ELX (200 MG OR 100 MG); TEZ; AND IVA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,517,564

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2018304168 ⤷  Subscribe
Australia 2023208222 ⤷  Subscribe
Brazil 112020000941 ⤷  Subscribe
Canada 3069226 ⤷  Subscribe
Chile 2020000122 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.